Cellbion셀비온
308430 · KOSDAQ · ₩308430 · 셀비온
₩11,940▲ ₩620 (5.48%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | ₩1.9B | ₩2.3B |
| Cost of sales | ₩1.9B | ₩1.3B |
| Gross profit | ₩89M | ₩967M |
| Operating income | −₩8.2B | −₩7.1B |
| Net income | −₩7.6B | −₩7.3B |
| Net income to shareholders | −₩7.6B | −₩7.3B |
Balance sheet
| 2025 | 2024 | |
|---|---|---|
| Total assets | ₩35B | ₩34B |
| Current assets | ₩25B | ₩32B |
| Cash and equivalents | ₩2B | ₩1.2B |
| Total liabilities | ₩12B | ₩4.8B |
| Current liabilities | ₩2.3B | ₩1.1B |
| Borrowings | ₩1.5B | ₩1.5B |
| Total equity | ₩23B | ₩30B |
| Shareholders' equity | ₩23B | ₩30B |
Cash flow
| 2025 | 2024 | |
|---|---|---|
| Cash from operations | −₩5.5B | −₩4.8B |
| Capital spending | ₩1.5B | ₩127M |
| Free cash flow | −₩7B | −₩4.9B |
Consolidated where available. Amounts in won.
Also known as: Cellbion / 셀비온 / 308430 / KRX:308430
Source: KRX statistical information